Released	Title	Price Sensitive	Download	Types
2025-01-06 08:55:00	Patient Enrolment Completed for INSIGHT-003	0	https://app.sharelinktechnologies.com/announcement/asx/af62403513d58ccfdbd20a6f0526428d	Progress Report
2025-01-22 09:02:00	Enrolment completed for Ph II trial in Soft Tissue Sarcoma	0	https://app.sharelinktechnologies.com/announcement/asx/bc5d7cdcff027208cb04639a2c3ea159	Progress Report
2025-01-31 08:27:00	Immutep Quarterly Activities Report and Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/89f7899a443be301a212c8751db99a61	Commitments Test Entity - Second Quarter Report Commitments Test Entity - Second Quarter Activity Report
2025-02-05 11:37:00	Immutep Corporate Presentation	0	https://app.sharelinktechnologies.com/announcement/asx/43e801e9d57c39f42958009177daccea	Company Presentation
2025-02-06 18:03:00	Notification of cessation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/6e2c330c40761e10495a51842a540a14	Appendix 3H (Notification of cessation of securities)
2025-02-26 18:58:00	Half Yearly Report and Accounts	1	https://app.sharelinktechnologies.com/announcement/asx/14fa7ee4e1f2d57b4d348c9c5f8e2cb5	Half Yearly Report Half Year Audit Review Half Year Directors' Statement Half Year Accounts Half Year Directors' Report
2025-03-20 10:29:00	TACTI-004 trial in progress poster to be presented at ELCC	0	https://app.sharelinktechnologies.com/announcement/asx/9327a9c3baf27cf0a8b9083e51cc938c	Company Administration - Other
2025-03-25 08:38:00	First patient dosed in phase 3 TACTI-004 lung cancer trial	1	https://app.sharelinktechnologies.com/announcement/asx/8362254961f3319e39bea0d1a3bfb767	Progress Report
2025-04-02 08:31:00	Immutep to Participate in Upcoming Investor Conferences	0	https://app.sharelinktechnologies.com/announcement/asx/4435ddb36cf7041058df465cfa647805	Company Administration - Other
2025-04-03 14:31:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/0edac415eea565880d062cb3ccb63724	Appendix 2A (Application for Quotation of Securities
2025-04-08 15:31:00	Change of Director's Interest Notice F Triebel	0	https://app.sharelinktechnologies.com/announcement/asx/35e707499eaa3f7bb2e19947849d4fd2	Change of Director's Interest Notice
2025-04-08 15:32:00	Change of Director's Interest Notice - M Voigt	0	https://app.sharelinktechnologies.com/announcement/asx/d2ca570fe3bf29729cb21aee1d1aa7eb	Change of Director's Interest Notice
2025-04-11 08:20:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/08ec4d827a686accd59f0fd9b4572d0c	Change in substantial holding
2025-04-23 10:24:00	Immutep Investor Update	0	https://app.sharelinktechnologies.com/announcement/asx/9be095e492507dee2d4e7565ccd37504	Periodic Reports - Other Progress Report
2025-04-29 09:02:00	Immutep Quarterly Activities Report and Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/8e27d8987e61776ab70a18fd64f28e37	Commitments Test Entity - Third Quarter Report Commitments Test Entity - Third Quarter Activity Report
2025-05-01 16:36:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/1e0b7ef777dc6073ef65cff60f977e4e	Change in substantial holding
2025-05-05 08:22:00	Excellent Overall Survival in Head & Neck Cancer Patients	1	https://app.sharelinktechnologies.com/announcement/asx/36f8811db1b59c48b4549d2db987bc75	Progress Report
2025-05-15 08:16:00	High Response Rates achieved in Lung Cancer in INSIGHT-003	1	https://app.sharelinktechnologies.com/announcement/asx/25674bf2c027d02adf5b0391c946f6e0	Progress Report
2025-05-26 08:22:00	Primary Endpoint Met in Phase II Soft Tissue Sarcoma Trial	1	https://app.sharelinktechnologies.com/announcement/asx/022d943cb0ccdc552f73e678bb1c2ac6	Progress Report
2025-06-02 08:21:00	Immutep Corporate Presentation	0	https://app.sharelinktechnologies.com/announcement/asx/e044181c5420c4410593b0f1f2b592f1	Company Presentation
2025-06-23 08:33:00	Update on Phase I Study of IMP761 for Autoimmune Diseases	1	https://app.sharelinktechnologies.com/announcement/asx/6cc1a51e0fc0dfec5e549e3968c33615	Progress Report
2025-06-30 16:39:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/2f22af211e20703475c7408565897810	Change in substantial holding
2025-07-17 08:19:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/8e3039aa74e94fc098b7c624b9634195	Change in substantial holding
2025-07-18 12:09:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/860d8ab027ed1eb84114647506366b60	Appendix 2A (Application for Quotation of Securities
2025-07-18 12:10:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/4cca40a473e63ea8d387c8f7ca4a1da9	Appendix 2A (Application for Quotation of Securities
2025-07-23 17:40:00	Ceasing to be a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/f74cd49d41da47a262c7e2a14e8f0f84	Ceasing to be a substantial holder
2025-07-25 08:16:00	Ceasing to be a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/673819b97b0242aeab69b28389a15751	Ceasing to be a substantial holder
2025-07-28 09:27:00	Abstracts Accepted for Presentation at ESMO Congress 2025	0	https://app.sharelinktechnologies.com/announcement/asx/17b5c52cd0b1366f90430c0dc8693171	Progress Report
2025-07-29 08:21:00	TACTI-004 trial in progress poster to be presented at WCLC	0	https://app.sharelinktechnologies.com/announcement/asx/a3acb8e1ab1cdd5a8aef4716e0a8c79d	Progress Report
2025-07-30 08:25:00	Immutep Quarterly Activities Report and Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/85e76cc941a5fdde0087c0d15d61a485	Commitments Test Entity - Fourth Quarter Report Commitments Test Entity - Fourth Quarter Activity Report